Department of Clinical Laboratory, Beijing Chao-Yang Hospital, Capital Medical University, 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, China.
Beijing Medical Laboratory Quality Control and Improvement Center, Beijing, China.
Virol J. 2023 Jun 8;20(1):119. doi: 10.1186/s12985-023-02032-z.
A variety of open-system real-time reverse transcriptase polymerase chain reaction (RT-PCR) assays for several acute respiratory syndrome coronavirus 2 are currently in use. This study aimed to ensure the quality of omicron nucleic acid testing and to assess the comparability of cycle threshold (Ct) values derived from RT-PCR.
Five external quality assessment (EQA) rounds using the omicron virus-like particles were organized between February 2022 and June 2022.
A total of 1401 qualitative EQA reports have been collected. The overall positive percentage agreement was 99.72%, the negative percentage agreement was 99.75%, and the percent agreement was 99.73%. This study observed a significant variance in Ct values derived from different test systems. There was a wide heterogeneity in PCR efficiency among different RT-PCR kits and inter-laboratories.
There was strong concordance among laboratories performing qualitative omicron nucleic acid testing. Ct values from qualitative RT-PCR tests should not be used for clinical or epidemiological decision-making to avoid the potential for misinterpretation of the results.
目前有多种用于检测多种急性呼吸综合征冠状病毒 2 的开放式实时逆转录聚合酶链反应(RT-PCR)检测方法。本研究旨在确保奥密克戎核酸检测质量,并评估 RT-PCR 得出的循环阈值(Ct)值的可比性。
2022 年 2 月至 2022 年 6 月期间组织了五轮奥密克戎病毒样颗粒的外部质量评估(EQA)。
共收集了 1401 份定性 EQA 报告。总体阳性百分比符合率为 99.72%,阴性百分比符合率为 99.75%,总符合率为 99.73%。本研究观察到不同检测系统得出的 Ct 值存在显著差异。不同 RT-PCR 试剂盒和实验室之间的 PCR 效率存在很大的异质性。
进行定性奥密克戎核酸检测的实验室之间具有很强的一致性。不应将定性 RT-PCR 检测的 Ct 值用于临床或流行病学决策,以避免对结果产生潜在的误解。